243 related articles for article (PubMed ID: 26719531)
1. Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types.
Chartier C; Raval J; Axelrod F; Bond C; Cain J; Dee-Hoskins C; Ma S; Fischer MM; Shah J; Wei J; Ji M; Lam A; Stroud M; Yen WC; Yeung P; Cancilla B; O'Young G; Wang M; Kapoun AM; Lewicki J; Hoey T; Gurney A
Cancer Res; 2016 Feb; 76(3):713-23. PubMed ID: 26719531
[TBL] [Abstract][Full Text] [Related]
2. R-Spondin potentiates Wnt/β-catenin signaling through orphan receptors LGR4 and LGR5.
Ruffner H; Sprunger J; Charlat O; Leighton-Davies J; Grosshans B; Salathe A; Zietzling S; Beck V; Therier M; Isken A; Xie Y; Zhang Y; Hao H; Shi X; Liu D; Song Q; Clay I; Hintzen G; Tchorz J; Bouchez LC; Michaud G; Finan P; Myer VE; Bouwmeester T; Porter J; Hild M; Bassilana F; Parker CN; Cong F
PLoS One; 2012; 7(7):e40976. PubMed ID: 22815884
[TBL] [Abstract][Full Text] [Related]
3. R-Spondin proteins: a novel link to beta-catenin activation.
Kim KA; Zhao J; Andarmani S; Kakitani M; Oshima T; Binnerts ME; Abo A; Tomizuka K; Funk WD
Cell Cycle; 2006 Jan; 5(1):23-6. PubMed ID: 16357527
[TBL] [Abstract][Full Text] [Related]
4. The role of R-spondin proteins in cancer biology.
Ter Steege EJ; Bakker ERM
Oncogene; 2021 Nov; 40(47):6469-6478. PubMed ID: 34663878
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the follistatin gene by RSPO-LGR4 signaling via activation of the WNT/β-catenin pathway in skeletal myogenesis.
Han XH; Jin YR; Tan L; Kosciuk T; Lee JS; Yoon JK
Mol Cell Biol; 2014 Feb; 34(4):752-64. PubMed ID: 24344199
[TBL] [Abstract][Full Text] [Related]
6. A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis.
Fang L; Zhu Q; Neuenschwander M; Specker E; Wulf-Goldenberg A; Weis WI; von Kries JP; Birchmeier W
Cancer Res; 2016 Feb; 76(4):891-901. PubMed ID: 26645562
[TBL] [Abstract][Full Text] [Related]
7. R-spondins are newly recognized players in osteoarthritis that regulate Wnt signaling in osteoblasts.
Abed É; Chan TF; Delalandre A; Martel-Pelletier J; Pelletier JP; Lajeunesse D
Arthritis Rheum; 2011 Dec; 63(12):3865-75. PubMed ID: 22127703
[TBL] [Abstract][Full Text] [Related]
8. R-Spondin family members regulate the Wnt pathway by a common mechanism.
Kim KA; Wagle M; Tran K; Zhan X; Dixon MA; Liu S; Gros D; Korver W; Yonkovich S; Tomasevic N; Binnerts M; Abo A
Mol Biol Cell; 2008 Jun; 19(6):2588-96. PubMed ID: 18400942
[TBL] [Abstract][Full Text] [Related]
9. Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth.
Jackson H; Granger D; Jones G; Anderson L; Friel S; Rycroft D; Fieles W; Tunstead J; Steward M; Wattam T; Walker A; Griggs J; Al-Hajj M; Shelton C
Mol Cancer Res; 2016 Sep; 14(9):859-68. PubMed ID: 27401612
[TBL] [Abstract][Full Text] [Related]
10. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
[TBL] [Abstract][Full Text] [Related]
11. RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations.
Fischer MM; Yeung VP; Cattaruzza F; Hussein R; Yen WC; Murriel C; Evans JW; O'Young G; Brunner AL; Wang M; Cain J; Cancilla B; Kapoun A; Hoey T
Sci Rep; 2017 Nov; 7(1):15270. PubMed ID: 29127379
[TBL] [Abstract][Full Text] [Related]
12. A WNT/beta-catenin signaling activator, R-spondin, plays positive regulatory roles during skeletal myogenesis.
Han XH; Jin YR; Seto M; Yoon JK
J Biol Chem; 2011 Mar; 286(12):10649-59. PubMed ID: 21252233
[TBL] [Abstract][Full Text] [Related]
13. Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia.
Salik B; Yi H; Hassan N; Santiappillai N; Vick B; Connerty P; Duly A; Trahair T; Woo AJ; Beck D; Liu T; Spiekermann K; Jeremias I; Wang J; Kavallaris M; Haber M; Norris MD; Liebermann DA; D'Andrea RJ; Murriel C; Wang JY
Cancer Cell; 2020 Aug; 38(2):263-278.e6. PubMed ID: 32559496
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization.
Tan B; Shi X; Zhang J; Qin J; Zhang N; Ren H; Qian M; Siwko S; Carmon K; Liu Q; Han H; Du B; Liu M
Cancer Res; 2018 Sep; 78(17):4929-4942. PubMed ID: 29967265
[TBL] [Abstract][Full Text] [Related]
15. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
Prosperi JR; Goss KH
Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
[TBL] [Abstract][Full Text] [Related]
16. The role of R-spondin 1 through activating Wnt/β-catenin in the growth, survival and migration of ovarian cancer cells.
Liu Q; Zhao Y; Xing H; Li L; Li R; Dai J; Li Q; Fang S
Gene; 2019 Mar; 689():124-130. PubMed ID: 30572097
[TBL] [Abstract][Full Text] [Related]
17.
Niu J; Guan J; Li R; Li X; Zhai J; Qi J; He Y
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966290
[No Abstract] [Full Text] [Related]
18. R-spondins are involved in the ovarian differentiation in a teleost, medaka (Oryzias latipes).
Zhou L; Charkraborty T; Yu X; Wu L; Liu G; Mohapatra S; Wang D; Nagahama Y
BMC Dev Biol; 2012 Dec; 12():36. PubMed ID: 23217106
[TBL] [Abstract][Full Text] [Related]
19. RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.
Carmon KS; Gong X; Yi J; Thomas A; Liu Q
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1221-9. PubMed ID: 24639526
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of R-spondins in triple-negative and metaplastic breast cancers.
Coussy F; Lallemand F; Vacher S; Schnitzler A; Chemlali W; Caly M; Nicolas A; Richon S; Meseure D; El Botty R; De-Plater L; Fuhrmann L; Dubois T; Roman-Roman S; Dangles-Marie V; Marangoni E; Bièche I
Br J Cancer; 2017 Jun; 116(12):1595-1603. PubMed ID: 28472820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
